Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy.
about
Pauci- and Multibacillary Leprosy: Two Distinct, Genetically Neglected DiseasesInflammatory Mediators of Leprosy Reactional Episodes and Dental Infections: A Systematic ReviewPre-miR-146a (rs2910164 G>C) single nucleotide polymorphism is genetically and functionally associated with leprosyWhole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases.IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosyLeprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.International open trial of uniform multidrug therapy regimen for leprosy patients: Findings & implications for national leprosy programmes.Number of leprosy reactions during treatment: clinical correlations and laboratory diagnosis.Genetic polymorphisms of the IL6 and NOD2 genes are risk factors for inflammatory reactions in leprosyAnti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.Grade 2 disabilities in leprosy patients from Brazil: Need for follow-up after completion of multidrug therapy
P2860
Q26746126-27C62603-2636-4C0E-BCFB-2444CEBA358BQ26785530-20955184-51F9-4F12-B7A6-AF4AF442B418Q28542768-E9AA0623-5513-4A7E-8A4A-293613632DF2Q33874225-BB493F80-DF85-4A34-B7D6-8A50382DA900Q34165767-3C896D4E-9BF3-4E4C-8286-D834F2B2C1F0Q36286311-8EE37292-80EC-450F-80DE-6540F6615C80Q37476358-96F10691-9303-4D06-8C01-9A6745CD73DAQ37692684-822EE9BD-0E58-4A3E-B9BC-5DEA89CA8DC6Q38779807-C5DB5C79-F0F1-4D7C-82BB-F17D311875EEQ41154742-0AC42ED7-B310-4A07-AF60-859819BE2A38Q55105127-58163F25-B15D-40DE-842D-6C97E888A4CCQ57952525-793EE340-16B5-4019-8624-92CCE3EBE350
P2860
Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification of clinical, ep ...... g and after multidrug therapy.
@ast
Identification of clinical, ep ...... g and after multidrug therapy.
@en
type
label
Identification of clinical, ep ...... g and after multidrug therapy.
@ast
Identification of clinical, ep ...... g and after multidrug therapy.
@en
prefLabel
Identification of clinical, ep ...... g and after multidrug therapy.
@ast
Identification of clinical, ep ...... g and after multidrug therapy.
@en
P2093
P2860
P356
P1476
Identification of clinical, ep ...... g and after multidrug therapy.
@en
P2093
Adeilson Vieira da Costa
Ana Carolina Sousa Rodrigues da Cunha
Douglas Eulálio Antunes
Gabriela Porto Ferreira
Maria Aparecida Gonçalves
Sergio Araujo
P2860
P304
P356
10.1590/0074-0276130222
P577
2013-11-01T00:00:00Z